MX2020012483A - Agente de aclaramiento de la piel. - Google Patents
Agente de aclaramiento de la piel.Info
- Publication number
- MX2020012483A MX2020012483A MX2020012483A MX2020012483A MX2020012483A MX 2020012483 A MX2020012483 A MX 2020012483A MX 2020012483 A MX2020012483 A MX 2020012483A MX 2020012483 A MX2020012483 A MX 2020012483A MX 2020012483 A MX2020012483 A MX 2020012483A
- Authority
- MX
- Mexico
- Prior art keywords
- sup
- skin lightening
- lightening agent
- hydrogen atom
- branched
- Prior art date
Links
- 239000007854 depigmenting agent Substances 0.000 title abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000006823 (C1-C6) acyl group Chemical group 0.000 abstract 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 206010040829 Skin discolouration Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/42—Colour properties
- A61K2800/43—Pigments; Dyes
- A61K2800/434—Luminescent, Fluorescent; Optical brighteners; Photosensitizers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
El objetivo es proporcionar un agente de blanqueamiento de la piel que tiene un excelente efecto de blanqueamiento de la piel. Un compuesto expresado por la siguiente Fórmula (1), o una sal de adición de ácido del mismo se utiliza como un ingrediente activo del agente de blanqueamiento de la piel: (ver Fórmula) en donde, X representa un grupo alquileno que tiene 1 a 2 átomos de carbono, donde un átomo de hidrógeno puede ser sustituido con un grupo metilo; Y representa COOR1 o CH2OR2; R1 representa un átomo de hidrógeno, o un grupo alquilo opcionalmente ramificado que tiene 1 a 6 átomos de carbono; y R2 representa un átomo de hidrógeno o un grupo acilo opcionalmente ramificado que tiene 1 a 6 átomos de carbono.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018101963 | 2018-05-29 | ||
| PCT/JP2019/017350 WO2019230274A1 (ja) | 2018-05-29 | 2019-04-24 | 美白剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2020012483A true MX2020012483A (es) | 2021-02-15 |
Family
ID=68696707
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2020012483A MX2020012483A (es) | 2018-05-29 | 2019-04-24 | Agente de aclaramiento de la piel. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US12151010B2 (es) |
| EP (1) | EP3804690B1 (es) |
| JP (1) | JP7239573B2 (es) |
| KR (1) | KR102513180B1 (es) |
| CN (1) | CN112135599B (es) |
| AU (1) | AU2019278251B2 (es) |
| BR (1) | BR112020023802B1 (es) |
| CA (1) | CA3101313C (es) |
| ES (1) | ES2992858T3 (es) |
| IL (1) | IL278816B2 (es) |
| MX (1) | MX2020012483A (es) |
| RU (1) | RU2757906C1 (es) |
| SG (1) | SG11202011525WA (es) |
| TW (1) | TWI874318B (es) |
| UA (1) | UA126100C2 (es) |
| WO (1) | WO2019230274A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021065895A1 (ja) * | 2019-09-30 | 2021-04-08 | 花王株式会社 | 日焼け止め化粧料 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6036418B2 (ja) * | 1980-07-21 | 1985-08-20 | 帝人株式会社 | アミノカルボン酸誘導体、その製造法及びそれを活性成分とする抗潰瘍剤 |
| JPS5846049A (ja) * | 1981-09-11 | 1983-03-17 | Teijin Ltd | アミノカルボン酸誘導体およびその製造法 |
| JPS63270650A (ja) | 1987-04-30 | 1988-11-08 | Asahi Chem Ind Co Ltd | Ｐ−（トランス−４−アミノメチルシクロヘキシルカルボニル）フエニルプロピオン酸の製造方法 |
| JPS644508A (en) | 1987-06-26 | 1989-01-09 | Daihatsu Motor Co Ltd | Hood lock structure of van type vehicle |
| US5719197A (en) | 1988-03-04 | 1998-02-17 | Noven Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
| JP2999203B2 (ja) * | 1989-08-29 | 2000-01-17 | 第一製薬株式会社 | 日腔用組成物 |
| EP0604667A4 (en) | 1992-07-22 | 1995-04-05 | Shiseido Co Ltd | TRANEXAMIC ACID DERIVATIVE AND DERMATOLOGICAL PREPARATION CONTAINING THE SAME. |
| ES2171459T3 (es) * | 1993-07-30 | 2002-09-16 | Teijin Ltd | Polvo para administracion nasal de farmaco peptidico o proteinaceo. |
| US6986901B2 (en) * | 2002-07-15 | 2006-01-17 | Warner-Lambert Company Llc | Gastrointestinal compositions |
| CN101378724A (zh) * | 2006-02-14 | 2009-03-04 | 宝丽化学工业有限公司 | 皮肤增白化妆品 |
| DE102006019044A1 (de) * | 2006-04-25 | 2007-10-31 | Merck Patent Gmbh | Antioxidantien |
| JP5133645B2 (ja) | 2006-10-02 | 2013-01-30 | 第一三共ヘルスケア株式会社 | セトラキサートを含有する美白剤 |
| RU2010102865A (ru) | 2007-07-24 | 2011-08-27 | НексБио, Инк. (US) | Технология изготовления микрочастиц |
| WO2009093534A1 (ja) | 2008-01-21 | 2009-07-30 | Shiseido Company, Ltd. | Ｖｅｇｆｃ産生促進剤 |
| JP5462504B2 (ja) * | 2008-03-21 | 2014-04-02 | 第一三共ヘルスケア株式会社 | 美白用組成物 |
| US9050293B2 (en) | 2008-07-16 | 2015-06-09 | Juventio, Llc | Small molecule solubilization system |
| KR101877575B1 (ko) * | 2009-12-16 | 2018-07-12 | 포라 가세이 고교 가부시키가이샤 | 색소 침착 예방 또는 개선제 |
| JP5911209B2 (ja) | 2011-06-14 | 2016-04-27 | ポーラ化成工業株式会社 | 皮膚外用剤 |
| BR112019010592B8 (pt) * | 2016-11-28 | 2022-09-06 | Pola Chem Ind Inc | Uso de um composto |
-
2019
- 2019-04-24 WO PCT/JP2019/017350 patent/WO2019230274A1/ja not_active Ceased
- 2019-04-24 IL IL278816A patent/IL278816B2/en unknown
- 2019-04-24 EP EP19812513.0A patent/EP3804690B1/en active Active
- 2019-04-24 ES ES19812513T patent/ES2992858T3/es active Active
- 2019-04-24 BR BR112020023802-3A patent/BR112020023802B1/pt active IP Right Grant
- 2019-04-24 US US17/057,320 patent/US12151010B2/en active Active
- 2019-04-24 JP JP2020521800A patent/JP7239573B2/ja active Active
- 2019-04-24 UA UAA202007934A patent/UA126100C2/uk unknown
- 2019-04-24 CA CA3101313A patent/CA3101313C/en active Active
- 2019-04-24 MX MX2020012483A patent/MX2020012483A/es unknown
- 2019-04-24 KR KR1020207033204A patent/KR102513180B1/ko active Active
- 2019-04-24 SG SG11202011525WA patent/SG11202011525WA/en unknown
- 2019-04-24 AU AU2019278251A patent/AU2019278251B2/en active Active
- 2019-04-24 RU RU2020140879A patent/RU2757906C1/ru active
- 2019-04-24 CN CN201980033386.7A patent/CN112135599B/zh active Active
- 2019-05-20 TW TW108117285A patent/TWI874318B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| BR112020023802A2 (pt) | 2021-02-23 |
| CN112135599A (zh) | 2020-12-25 |
| EP3804690B1 (en) | 2024-06-05 |
| IL278816B2 (en) | 2023-11-01 |
| US12151010B2 (en) | 2024-11-26 |
| IL278816B1 (en) | 2023-07-01 |
| SG11202011525WA (en) | 2020-12-30 |
| BR112020023802B1 (pt) | 2023-10-31 |
| IL278816A (en) | 2021-01-31 |
| RU2757906C1 (ru) | 2021-10-22 |
| ES2992858T3 (en) | 2024-12-18 |
| KR102513180B1 (ko) | 2023-03-23 |
| TWI874318B (zh) | 2025-03-01 |
| JPWO2019230274A1 (ja) | 2021-06-17 |
| UA126100C2 (uk) | 2022-08-10 |
| AU2019278251A1 (en) | 2020-12-10 |
| WO2019230274A1 (ja) | 2019-12-05 |
| EP3804690A4 (en) | 2022-06-08 |
| CA3101313C (en) | 2023-01-24 |
| CN112135599B (zh) | 2023-03-31 |
| CA3101313A1 (en) | 2019-12-05 |
| JP7239573B2 (ja) | 2023-03-14 |
| NZ770176A (en) | 2024-02-23 |
| KR20210003827A (ko) | 2021-01-12 |
| US20210196599A1 (en) | 2021-07-01 |
| EP3804690A1 (en) | 2021-04-14 |
| TW202015653A (zh) | 2020-05-01 |
| AU2019278251B2 (en) | 2021-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20090195T1 (hr) | Inhibitori mitotičkih kinezina | |
| HRP20090162T1 (en) | Quinolinone-carboxamide compounds as 5-ht4 receptor agonists | |
| HUP0301607A2 (hu) | Szelektív neurokinin antagonista hatású nitrogéntartalmú heterociklusos vegyületek, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| AR060545A1 (es) | Compuestos de benzoaxol y benzotiazol 6-0- sustituidos y metodos de inhibicion de la senalizacion de csf-1r. composiciones farmaceuticas | |
| HRP20070203T3 (hr) | Derivati n-[fenil(alkilpiperidin-2-il)metil]benzamida, njihovo dobivanje i njihova primjena u terapiji | |
| TW200745058A (en) | MMP-13 selective inhibitors | |
| MX394836B (es) | Derivado de anillo fusionado que tiene una actividad inhibidora de monoacilglicerol aciltransferasa 2 (mgat-2) | |
| JO3261B1 (ar) | مشتق بيريدين أحادي الحلقة | |
| DK1485377T3 (da) | Pyranoner egnede som ATM-inhibitorer | |
| MX2018011716A (es) | Compuesto de piridazinona o su sal, y herbicida que lo contiene. | |
| GB2420781B (en) | Aminopyrones and their use as ATM inhibitors | |
| PH12018502012B1 (en) | Griseofulvin compound | |
| MX2020001615A (es) | Compuestos de piridina sustituidos con azol. | |
| TW200612920A (en) | Novel imidazolidine derivatives | |
| HRP20090474T1 (hr) | Postupak i intermedijeri za sintezu kaspofungina | |
| MX2013007296A (es) | Derivado novedoso de isoquinolina sustituido. | |
| MX2013007938A (es) | Compuesto biciclico novedoso o sal del mismo. | |
| SE0201658D0 (sv) | Immediate release pharmaceutical formulation | |
| CR7249A (es) | Derivados de diamina, proceso para producir los derivados de diamina, y funguicidas que contienen los derivados de diamina como ingrediente activo | |
| MY184153A (en) | A chemical treatment solution for formation damage at near wellbore | |
| MY185558A (en) | Pyrido-oxazinone derivatives as tnap inhibitors | |
| MX2020012483A (es) | Agente de aclaramiento de la piel. | |
| EA202192378A1 (ru) | Противогрибковые композиции | |
| IN2012DN01251A (es) | ||
| PH12022550797A1 (en) | Dysuria-alleviating agent |